Role of the local renin-angiotensin system in cardiac damage: A minireview focussing on transgenic animal models
M. Bader Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models J. Mol. Cell Cardiol. 34 2002 1455 1462
Role of angiotensin receptor blockers in patients with left ventricular dysfunction: Lessons from CHARM and VALIANT
(in press)
Voors, A.A. and van Veldhuisen, D.J. (2004) Role of angiotensin receptor blockers in patients with left ventricular dysfunction: lessons from CHARM and VALIANT. Int. J. Cardiol. (in press)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial
J.J. McMurray Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Lancet 362 2003 767 771
Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor
W.G. Thomas Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor Circ. Res. 90 2002 135 142
A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy
B.H. Shah, and K.J. Catt A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy Trends Pharmacol. Sci. 24 2003 239 244
Lys199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists
F.L. Fierens Lys199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists J. Renin Angiotensin. Aldosterone. Syst. 1 2000 283 288
Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist
N. Lochard Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist Circ. Res. 94 2004 1451 1457
Angiotensin IV stimulates the activity of tyrosine kinases in rat anterior pituitary gland acting via AT1-like receptors?
E. Rebas Angiotensin IV stimulates the activity of tyrosine kinases in rat anterior pituitary gland acting via AT1-like receptors? J. Physiol Pharmacol. 55 2004 107 111
Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N- and C-terminal residues of angiotensin II during AT1 receptor activation
M.T. Le Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N- and C-terminal residues of angiotensin II during AT1 receptor activation J. Biol. Chem. 277 2002 23107 23110
Intracellular angiotensin II fusion protein alters AT1 receptor fusion protein distribution and activates CREB
J.L. Cook Intracellular angiotensin II fusion protein alters AT1 receptor fusion protein distribution and activates CREB J. Mol. Cell Cardiol. 36 2004 75 90
Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: A functional role for receptor-receptor interaction in vivo
L. Barki-Harrington Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo Circulation 108 2003 1611 1618
